{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T21:48:45Z","timestamp":1789076925550,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["223004"],"award-info":[{"award-number":["223004"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024871","name":"Sociale en Geesteswetenschappen, NWO","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol Myers Squibb","doi-asserted-by":"publisher","award":["2001 D 032"],"award-info":[{"award-number":["2001 D 032"]}],"id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.aohep.2025.102170","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T17:16:45Z","timestamp":1764782205000},"page":"102170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Genetic risk factors for MASLD\/MASH and cardiovascular disease in elderly individuals"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3639-0963","authenticated-orcid":false,"given":"Willy B.","family":"Theel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4692-479X","authenticated-orcid":false,"given":"Vivian D.","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diederick E.","family":"Grobbee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Wouter","family":"Jukema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Trompet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5164-2082","authenticated-orcid":false,"given":"Manuel","family":"Castro Cabezas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.aohep.2025.102170_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2023.101133","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"29","author":"Rinella","year":"2024","journal-title":"Ann Hepatol"},{"issue":"1","key":"10.1016\/j.aohep.2025.102170_bib0002","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cmet.2019.12.002","article-title":"Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease","volume":"31","author":"Romeo","year":"2020","journal-title":"Cell Metab"},{"issue":"5","key":"10.1016\/j.aohep.2025.102170_bib0003","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1053\/gast.2001.23256","article-title":"Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities","volume":"120","author":"Sanyal","year":"2001","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.aohep.2025.102170_bib0004","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.27368","article-title":"Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up","volume":"61","author":"Ekstedt","year":"2015","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.aohep.2025.102170_bib0005","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1055\/s-0035-1550065","article-title":"Fibrosis in nonalcoholic Fatty liver disease: mechanisms and clinical implications","volume":"35","author":"Angulo","year":"2015","journal-title":"Semin Liver Dis"},{"issue":"14","key":"10.1016\/j.aohep.2025.102170_bib0006","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMra0912063","article-title":"Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease","volume":"363","author":"Targher","year":"2010","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.aohep.2025.102170_bib0007","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.aohep.2025.102170_bib0008","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1161\/ATV.0000000000000153","article-title":"Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association","volume":"42","author":"Duell","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"10.1016\/j.aohep.2025.102170_bib0009","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","year":"2024","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.aohep.2025.102170_bib0010","doi-asserted-by":"crossref","DOI":"10.1111\/eci.14368","article-title":"Trompet S. Risk of cardiovascular disease in elderly subjects with obesity and liver fibrosis and the potential benefit of statin treatment","volume":"55","author":"Theel","year":"2025","journal-title":"Eur J Clin Invest"},{"issue":"4","key":"10.1016\/j.aohep.2025.102170_bib0011","article-title":"Pravastatin reduces all-cause mortality in elderly individuals at risk of liver fibrosis: Post hoc analysis of the PROSPER trial","volume":"7","author":"de Jong","year":"2025","journal-title":"JHEP Rep"},{"issue":"6","key":"10.1016\/j.aohep.2025.102170_bib0012","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.jhep.2020.02.020","article-title":"Update on NAFLD genetics: From new variants to the clinic","volume":"72","author":"Trepo","year":"2020","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.aohep.2025.102170_bib0013","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jhep.2020.04.003","article-title":"Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort(\u2606)","volume":"73","author":"Anstee","year":"2020","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.aohep.2025.102170_bib0014","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jhep.2020.03.032","article-title":"Genome-wide and Mendelian randomisation studies of liver MRI yield insights into the pathogenesis of steatohepatitis","volume":"73","author":"Parisinos","year":"2020","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.aohep.2025.102170_bib0015","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/s41588-022-01078-z","article-title":"A multiancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological validation","volume":"54","author":"Vujkovic","year":"2022","journal-title":"Nat Genet"},{"key":"10.1016\/j.aohep.2025.102170_bib0016","doi-asserted-by":"crossref","DOI":"10.1007\/s12072-024-10769-0","article-title":"Genetic predisposition of metabolic dysfunction-associated steatotic liver disease: a population-based genome-wide association study","author":"Wang","year":"2025","journal-title":"Hepatol Int"},{"issue":"12","key":"10.1016\/j.aohep.2025.102170_bib0017","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1038\/s41591-024-03283-1","article-title":"Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver disease","volume":"30","author":"Raverdy","year":"2024","journal-title":"Nat Med"},{"issue":"9-10","key":"10.1016\/j.aohep.2025.102170_bib0018","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00508-023-02196-2","article-title":"No association of NAFLD-related polymorphisms in PNPLA3 and TM6SF2 with all-cause and cardiovascular mortality in an Austrian population study","volume":"136","author":"Semmler","year":"2024","journal-title":"Wien Klin Wochenschr"},{"issue":"6","key":"10.1016\/j.aohep.2025.102170_bib0019","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/apt.16772","article-title":"NAFLD-related gene polymorphisms and all-cause and cause-specific mortality in an Asian population: the Shanghai Changfeng Study","volume":"55","author":"Xia","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.aohep.2025.102170_bib0020","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/ijpo.12032","article-title":"TM6SF2 Glu167Lys polymorphism is associated with low levels of LDL-cholesterol and increased liver injury in obese children","volume":"11","author":"Grandone","year":"2016","journal-title":"Pediatr Obes"},{"issue":"9346","key":"10.1016\/j.aohep.2025.102170_bib0021","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","article-title":"Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial","volume":"360","author":"Shepherd","year":"2002","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.aohep.2025.102170_bib0022","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S0002-9149(99)00533-0","article-title":"The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at Risk","volume":"84","author":"Shepherd","year":"1999","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.aohep.2025.102170_bib0023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038240","article-title":"Genome-wide study of gene variants associated with differential cardiovascular event reduction by pravastatin therapy","volume":"7","author":"Shiffman","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.aohep.2025.102170_bib0024","article-title":"Identification of 90 NAFLD GWAS loci and establishment of NAFLD PRS and causal role of NAFLD in coronary artery disease","volume":"3","author":"Miao","year":"2022","journal-title":"HGG Adv"},{"issue":"6","key":"10.1016\/j.aohep.2025.102170_bib0025","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.aohep.2025.102170_bib0026","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/ajg.2016.453","article-title":"Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis","volume":"112","author":"McPherson","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.aohep.2025.102170_bib0027","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ajg.2023.10.001","article-title":"Liver fibrosis in pars cohort study: A large-scale study on the prevalence and correlated factors","volume":"24","author":"Nakhostin-Ansari","year":"2023","journal-title":"Arab J Gastroenterol"},{"issue":"1","key":"10.1016\/j.aohep.2025.102170_bib0028","doi-asserted-by":"crossref","first-page":"e986","DOI":"10.1097\/MEG.0000000000002340","article-title":"Prospective screening for significant liver fibrosis by fibrosis-4 in primary care patients without known liver disease","volume":"33","author":"Ouzan","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.aohep.2025.102170_bib0029","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/apt.13889","article-title":"Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease","volume":"45","author":"Petta","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.aohep.2025.102170_bib0030","article-title":"Liver Disease-Related Sarcopenia: A Predictor of Poor Prognosis by Accelerating Hepatic Decompensation in Advanced Chronic Liver Disease","volume":"15","author":"Nakamura","year":"2023","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.aohep.2025.102170_bib0031","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/MEG.0000000000001475","article-title":"Sarcopenia assessed using bioimpedance analysis is associated independently with significant liver fibrosis in patients with chronic liver diseases","volume":"32","author":"Hyun Kim","year":"2020","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.aohep.2025.102170_bib0032","doi-asserted-by":"crossref","first-page":"191","DOI":"10.23736\/S0026-4806.19.05978-0","article-title":"Older age and HDL-cholesterol as independent predictors of liver fibrosis assessed by BARD score","volume":"110","author":"Klisic","year":"2019","journal-title":"Minerva Med"},{"issue":"11","key":"10.1016\/j.aohep.2025.102170_bib0033","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/hepr.12840","article-title":"Development of hepatocellular carcinoma in Japanese patients with biopsy-proven non-alcoholic fatty liver disease: Association between PNPLA3 genotype and hepatocarcinogenesis\/fibrosis progression","volume":"47","author":"Seko","year":"2017","journal-title":"Hepatol Res"},{"issue":"10","key":"10.1016\/j.aohep.2025.102170_bib0034","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.31076","article-title":"Genetic Variants in the SAMM50 Gene Create Susceptibility to Nonalcoholic Fatty Liver Disease in a Chinese Han Population","volume":"15","author":"Chen","year":"2015","journal-title":"Hepat Mon"},{"issue":"5","key":"10.1016\/j.aohep.2025.102170_bib0035","first-page":"591","article-title":"[Crosstalk between canonical TGF-beta\/Smad and Wnt\/beta-catenin signaling pathway]","volume":"42","author":"Rao","year":"2013","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"issue":"4","key":"10.1016\/j.aohep.2025.102170_bib0036","doi-asserted-by":"crossref","first-page":"337","DOI":"10.33549\/physiolres.932289","article-title":"Wnt\/beta-catenin signaling: a promising new target for fibrosis diseases","volume":"61","author":"Guo","year":"2012","journal-title":"Physiol Res"},{"issue":"12","key":"10.1016\/j.aohep.2025.102170_bib0037","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1172\/JCI44213","article-title":"Trib1 is a lipid- and myocardial infarction-associated gene that regulates hepatic lipogenesis and VLDL production in mice","volume":"120","author":"Burkhardt","year":"2010","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.aohep.2025.102170_bib0038","doi-asserted-by":"crossref","first-page":"L1127","DOI":"10.1152\/ajplung.00057.2008","article-title":"The human zinc transporter SLC39A8 (Zip8) is critical in zinc-mediated cytoprotection in lung epithelia","volume":"294","author":"Besecker","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"10.1016\/j.aohep.2025.102170_bib0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5483\/BMBRep.2014.47.1.285","article-title":"Role of vascular smooth muscle cell in the inflammation of atherosclerosis","volume":"47","author":"Lim","year":"2014","journal-title":"BMB Rep"},{"issue":"6","key":"10.1016\/j.aohep.2025.102170_bib0040","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2174\/092986707780059571","article-title":"The structure and main functions of aminopeptidase N","volume":"14","author":"Luan","year":"2007","journal-title":"Curr Med Chem"},{"issue":"1-2","key":"10.1016\/j.aohep.2025.102170_bib0041","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11010-012-1449-x","article-title":"Topical application of aminopeptidase N-neutralizing antibody accelerates wound closure","volume":"372","author":"Lai","year":"2013","journal-title":"Mol Cell Biochem"},{"issue":"4","key":"10.1016\/j.aohep.2025.102170_bib0042","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00018-005-5296-8","article-title":"Metastasis: cell-autonomous mechanisms versus contributions by the tumor microenvironment","volume":"63","author":"Kopfstein","year":"2006","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"10.1016\/j.aohep.2025.102170_bib0043","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/bjc.2012.549","article-title":"Prognostic significance of aberrantly silenced ANPEP expression in prostate cancer","volume":"108","author":"Sorensen","year":"2013","journal-title":"Br J Cancer"},{"issue":"7","key":"10.1016\/j.aohep.2025.102170_bib0044","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1007\/s10147-020-01651-8","article-title":"ACO2 and ANPEP as novel prognostic markers for gallbladder squamous cell\/adenosquamous carcinomas and adenocarcinomas","volume":"25","author":"Liu","year":"2020","journal-title":"Int J Clin Oncol"},{"issue":"2","key":"10.1016\/j.aohep.2025.102170_bib0045","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00428-012-1347-3","article-title":"AZGP1 and SPDEF mRNA expression differentiates breast carcinoma from ovarian serous carcinoma","volume":"462","author":"Stavnes","year":"2013","journal-title":"Virchows Arch"},{"issue":"3","key":"10.1016\/j.aohep.2025.102170_bib0046","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/ajg.2013.476","article-title":"The effect of PNPLA3 on fibrosis progression and development of hepatocellular carcinoma: a meta-analysis","volume":"109","author":"Singal","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.aohep.2025.102170_bib0047","doi-asserted-by":"crossref","first-page":"e231","DOI":"10.1210\/clinem\/dgae264","article-title":"LDL-C and TC Mediate the Risk of PNPLA3 Inhibition in Cardiovascular Diseases","volume":"110","author":"Zhang","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.aohep.2025.102170_bib0048","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/EDE.0000000000001072","article-title":"Survival Bias in Mendelian Randomization Studies: A Threat to Causal Inference","volume":"30","author":"Smit","year":"2019","journal-title":"Epidemiology,"},{"issue":"5","key":"10.1016\/j.aohep.2025.102170_bib0049","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.28674","article-title":"Shared genetic effects between hepatic steatosis and fibrosis: A prospective twin study","volume":"64","author":"Cui","year":"2016","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.aohep.2025.102170_bib0050","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.numecd.2019.06.002","article-title":"PNPLA3 gene polymorphism in Brazilian patients with type 2 diabetes: A prognostic marker beyond liver disease?","volume":"29","author":"Machado","year":"2019","journal-title":"Nutr Metab Cardiovasc Dis"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268125003953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268125003953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T08:49:51Z","timestamp":1780649391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268125003953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1665268125003953"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2025.102170","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic risk factors for MASLD\/MASH and cardiovascular disease in elderly individuals","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2025.102170","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"102170"}}